Statement Of Financial Position [Abstract]

Zealand Pharma - Filing #1350008

Concept As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Property, plant and equipment
47,047,000 DKK
50,528,000 DKK
Right-of-use assets
102,805,000 DKK
114,960,000 DKK
Intangible assets other than goodwill
12,255,000 DKK
- DKK
Trade and other non-current receivables
15,794,000 DKK
18,105,000 DKK
Deferred tax assets
925,000 DKK
2,017,000 DKK
Other non-current financial assets
7,375,000 DKK
6,901,000 DKK
Non-current assets
200,205,000 DKK
223,454,000 DKK
Current assets [abstract]
Current inventories
7,935,000 DKK
1,286,000 DKK
Trade and other current receivables
122,359,000 DKK
115,622,000 DKK
Current tax assets, current
16,437,000 DKK
21,599,000 DKK
Cash and cash equivalents
449,311,000 DKK
1,069,234,000 DKK
1,129,103,000 DKK
Current assets
1,779,788,000 DKK
1,316,352,000 DKK
Assets
1,979,993,000 DKK
1,539,806,000 DKK
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
58,751,000 DKK
51,702,000 DKK
Retained earnings
4,894,841,000 DKK
4,171,640,000 DKK
Share premium
6,406,225,000 DKK
4,921,232,000 DKK
Equity
6,406,225,000 DKK
58,751,000 DKK
22,704,000 DKK
4,894,841,000 DKK
1,592,839,000 DKK
815,911,000 DKK
4,921,232,000 DKK
4,171,640,000 DKK
51,702,000 DKK
14,617,000 DKK
927,803,000 DKK
3,021,979,000 DKK
3,891,993,000 DKK
14,155,000 DKK
43,634,000 DKK
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current liabilities
102,575,000 DKK
528,404,000 DKK
Current liabilities [abstract]
Trade and other current payables
267,924,000 DKK
180,762,000 DKK
Current liabilities
284,579,000 DKK
195,491,000 DKK
Liabilities
387,154,000 DKK
723,895,000 DKK
Equity and liabilities
1,979,993,000 DKK
1,539,806,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.